Compare C J Gelatine with Similar Stocks
Dashboard
With HIgh Debt (Debt-Equity Ratio at 5.01 times)- the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Operating profit has grown by an annual rate -10.47% of over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at 2.37 times
- The company has been able to generate a Return on Equity (avg) of 7.51% signifying low profitability per unit of shareholders funds
Flat results in Dec 25
Stock DNA
Specialty Chemicals
INR 8 Cr (Micro Cap)
138.00
38
0.00%
5.01
1.44%
1.98
Total Returns (Price + Dividend) 
C J Gelatine for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

C J Gelatine Products Ltd Valuation Shifts to Very Attractive Amid Market Volatility
C J Gelatine Products Ltd, a player in the Specialty Chemicals sector, has witnessed a significant shift in its valuation parameters, moving from an attractive to a very attractive rating despite a recent sell rating downgrade. This article analyses the evolving price attractiveness of the stock through key valuation metrics such as price-to-earnings (P/E) and price-to-book value (P/BV) ratios, comparing them with historical trends and peer averages to provide a comprehensive view for investors.
Read full news article
C J Gelatine Products Ltd Downgraded to Sell Amid Mixed Financial and Technical Signals
C J Gelatine Products Ltd, a specialty chemicals company, has seen its investment rating downgraded from Hold to Sell as of 24 February 2026. This revision reflects a combination of deteriorating technical indicators, weak financial trends, and concerns over valuation and quality metrics. The company’s current Mojo Score stands at 44.0, signalling a Sell recommendation amid a challenging operating environment and subdued growth prospects.
Read full news article
C J Gelatine Products Ltd Upgraded to Hold on Technical Improvements and Valuation Appeal
C J Gelatine Products Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in technical indicators and valuation metrics despite ongoing challenges in financial performance and long-term fundamentals. The upgrade, effective from 19 Feb 2026, is driven primarily by bullish technical trends and attractive valuation ratios, positioning the stock as a cautious buy within the Specialty Chemicals sector.
Read full news article Announcements 
Announcement under Regulation 30 (LODR)-Newspaper Publication
09-Feb-2026 | Source : BSEThe Company has published in newspapers the unaudited financial results for the quarter and nine months ended December 31 2025. The same were published within 48 hours of the conclusion of the meeting of the Board of Directors of the Company held on February 7 2026 wherein the aforesaid results were duly approved. Please find attached the same.
Unaudited Integrated Financial Results For The Period Ended December 31 2025.
07-Feb-2026 | Source : BSEPlease find attached herewith the integrated unaudited standalone financial results of the Company for the Quarter and Nine Months ended December 31 2025 along with Limited Review Report issued by the Statutory Auditors of the Company.
Board Meeting Outcome for Meeting Held Today I.E. Saturday February 7 2026
07-Feb-2026 | Source : BSEThe Board of Directors of the Company at their Meeting held on today i.e. Saturday February 7 2026 have inter-alia considered and approved the Unaudited Financial Results / Statements of the Company for the Quarter and Nine Months ended December 31 2025 along-with Limited Review Report. The aforesaid Board Meeting was commenced at 1:30 p.m. (IST) and concluded at 4:00 p.m. (IST).
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Jaspal Singh (57.49%)
Krishan Kumar Amla (4.01%)
35.68%
Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ
QoQ Growth in quarter ended Dec 2025 is -15.63% vs 43.25% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is 175.00% vs 128.57% in Sep 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 8.11% vs -5.67% in Sep 2024
Growth in half year ended Sep 2025 is 50.00% vs 86.11% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is 2.71% vs 0.88% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 133.33% vs 98.27% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is 0.98% vs 11.11% in Mar 2024
YoY Growth in year ended Mar 2025 is 104.10% vs -947.83% in Mar 2024






